Meeting
2018 Gastrointestinal Cancers Symposium
A phase II study of durvalumab following multimodality therapy for locally advanced esophageal adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-ESO14-012 study.
Authors
Hirva Mansurali Mamdani
Indiana University, Indianapolis, IN
Hirva Mansurali Mamdani , Laith I. Abushahin , Bryan J. Schneider , Rozina A. Chowdhery , Borys Hrinczenko , Ahran Lee , Susan M. Perkins , Kenneth Kesler , Shadia Ibrahim Jalal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT02639065
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr TPS194)
DOI
10.1200/JCO.2018.36.4_suppl.TPS194
Abstract #
TPS194
Poster Bd #
M8
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Safety and efficacy of durvalumab following trimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Early efficacy results from Big Ten Cancer Research Consortium study.
First Author: Hirva Mamdani
Poster
2020 ASCO Virtual Scientific Program
Durvalumab following multimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Updated survival and early translational results from Big Ten Cancer Research Consortium Study.
First Author: Hirva Mamdani
Poster
2021 ASCO Annual Meeting
Randomized phase III Trial of MEDI4736 (durvalumab) as concurrent and consolidative therapy or consolidative therapy alone for unresectable stage 3 NSCLC: A trial of the ECOG-ACRIN Cancer Research Group (EA5181).
First Author: John M. Varlotto
Poster
2019 ASCO Annual Meeting
Safety and efficacy of durvalumab following multimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Results from big ten cancer research consortium study.
First Author: Hirva Mamdani